IR contact detailsRoman Akbar-HaaseDirector Investor Relations and Business Developmente: ir@moonlaketx.com Upcoming events Jul 14 - Jul 15 2026 Leerink I&I and Metabolism Therapeutics Forum, Boston, MA Jul 28 - Jul 29 2026 BTIG Annual Biotechnology Conference, Virtual Sep 9 - Sep 10 2026 Citi's 2026 Biopharma Back to School Conference View All Events View All Events + Corporate presentations MoonLake Investor Day (Jun 2026) MoonLake Investor Day (Feb 2026) Clinical Data Update (Nov 2025) View All Presentations View All Presentations + Latest press releases Jun 23 2026 MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering Jun 22 2026 MoonLake Immunotherapeutics Announces Proposed Public Offering Jun 21 2026 MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026 View All News View All Press Releases +
Jun 21 2026 MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026